Novartis weighs takeover bid for Avidity Biosciences, reveals the FT - Part 3

So rather than several months it took just several weeks (well around six weeks) for Swiss pharmaceutical giant Novartis to return with a proper takeover offer for Avidity Biosciences, the US-listed biotechnology company.